ENTITY
Gland Pharma

Gland Pharma (GLAND IN)

104
Analysis
Health Care • India
Gland Pharma is a leading pharmaceutical company specializing in the manufacturing and marketing of complex injectables, operating primarily under a business-to-business (B2B) model. The company provides contract development and manufacturing organization (CDMO) services and out-licenses its generic injectable portfolio globally. Headquartered in Hyderabad, India, it was founded in 1978.
more
bullish•JD Health
•29 Nov 2020 13:02

ECM Weekly (29 November 2020) - JD Health, Evergrande Svcs, CR Svcs, Pop Mart, Nuix and More

A few big IPOs launched in Hong Kong this week, namely, JD Health, Evergrande Services, and CR Mixc Services. Interestingly, the trio drew strong...

Share
bullish•Gland Pharma
•19 Nov 2020 13:36

Gland Pharma IPO Trading - Squeezed Through, Now for the Real Test

Gland Pharma raised around US$900m in one of India’s largest IPOs in 2020. The company was established in 1978. KKR invested in 2014 and Fosun...

Logo
478 Views
Share
bullish•Ant Group
•08 Nov 2020 10:26

ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Gland Pharma
•05 Nov 2020 18:13

Gland Pharma IPO - High on Growth but Low on Details

Gland Pharma aims to raise around US$900m in what would be one of India’s largest IPOs in 2020. Fosun PharmaceuticalĀ  bought a 74% stake in the...

Logo
580 Views
Share
bullish•Gland Pharma
•05 Nov 2020 00:26

Gland Pharma IPO Initiation: Much Ado About Something

Gland has launched India’s biggest pharma IPO to raise as much as Rs64.5 billion ($871 million). Gland has attractive fundamentals to capitalise on...

Logo
366 Views
Share
x